H. Goldschmidt

974 total citations
34 papers, 447 citations indexed

About

H. Goldschmidt is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, H. Goldschmidt has authored 34 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 15 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in H. Goldschmidt's work include Multiple Myeloma Research and Treatments (20 papers), Cancer Treatment and Pharmacology (7 papers) and Protein Degradation and Inhibitors (5 papers). H. Goldschmidt is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Cancer Treatment and Pharmacology (7 papers) and Protein Degradation and Inhibitors (5 papers). H. Goldschmidt collaborates with scholars based in Germany, France and United States. H. Goldschmidt's co-authors include Anthony D. Ho, Gerlinde Egerer, M. Hensel, Andreas Schneeweiß, Dirk Hose, Jean‐François Rossi, Alboukadel Kassambara, Laure Vincent, Bernard Klein and Stefan Hohaus and has published in prestigious journals such as Blood, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

H. Goldschmidt

31 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Goldschmidt Germany 11 265 228 147 60 36 34 447
Francesca Carobolante Italy 6 406 1.5× 274 1.2× 215 1.5× 64 1.1× 84 2.3× 7 496
Christine M. Segeren Netherlands 13 502 1.9× 282 1.2× 368 2.5× 73 1.2× 31 0.9× 21 710
MR Litzow United States 14 517 2.0× 260 1.1× 237 1.6× 78 1.3× 32 0.9× 14 631
M Gaspard France 11 173 0.7× 171 0.8× 84 0.6× 38 0.6× 59 1.6× 28 467
Laura Cannella Italy 13 286 1.1× 137 0.6× 65 0.4× 186 3.1× 27 0.8× 37 483
Diane Weber United States 7 339 1.3× 198 0.9× 202 1.4× 42 0.7× 27 0.8× 13 457
Clifton C. Mo United States 11 242 0.9× 177 0.8× 216 1.5× 69 1.1× 73 2.0× 44 489
Natalie Pui Ha Chan Hong Kong 9 293 1.1× 68 0.3× 103 0.7× 73 1.2× 83 2.3× 21 475
Anna Pawłowska United States 11 125 0.5× 95 0.4× 124 0.8× 65 1.1× 33 0.9× 44 465
Samer Al Hadidi United States 12 310 1.2× 324 1.4× 211 1.4× 62 1.0× 76 2.1× 111 609

Countries citing papers authored by H. Goldschmidt

Since Specialization
Citations

This map shows the geographic impact of H. Goldschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Goldschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Goldschmidt more than expected).

Fields of papers citing papers by H. Goldschmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Goldschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Goldschmidt. The network helps show where H. Goldschmidt may publish in the future.

Co-authorship network of co-authors of H. Goldschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of H. Goldschmidt. A scholar is included among the top collaborators of H. Goldschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Goldschmidt. H. Goldschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dholaria, Bhagirathbhai, Katja Weisel, María‐Victoria Mateos, et al.. (2023). POSTER: MM-161 Talquetamab + Daratumumab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Updated TRIMM-2 Results. Clinical Lymphoma Myeloma & Leukemia. 23. S216–S216. 1 indexed citations
2.
3.
4.
Bischoff, Moritz S., Bastian Schmack, Michael C. Tanner, et al.. (2016). Pelottierung der A. thoracica descendens durch einen Zementsporn. Der Orthopäde. 45(11). 994–997.
5.
Herviou, Laurie, Anja Seckinger, Nicolas Robert, et al.. (2015). Inhibition of H3K9 methyltransferase as a potent therapeutic target in multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 15. e214–e215. 1 indexed citations
6.
7.
Hose, Dirk, Alboukadel Kassambara, Laure Vincent, et al.. (2010). Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation. Leukemia. 24(11). 1940–1950. 66 indexed citations
8.
Kumar, Shaji, Joan Bladé, John Crowley, et al.. (2009). Natural History of Multiple Myeloma Relapsing After Therapy with IMiDs and Bortezomib: A Multicenter International Myeloma Working Group Study.. Blood. 114(22). 2878–2878. 14 indexed citations
9.
Hundemer, Michael, Ulrike Klein, Dirk Hose, et al.. (2007). Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14). Bone Marrow Transplantation. 40(11). 1033–1037. 46 indexed citations
10.
Mahtouk, Karène, Dirk Hose, John De Vos, et al.. (2007). Input of DNA Microarrays to Identify Novel Mechanisms in Multiple Myeloma Biology and Therapeutic Applications. Clinical Cancer Research. 13(24). 7289–7295. 15 indexed citations
11.
Wasser, K., Thomas Moehler, Kai Neben, et al.. (2004). Dynamische MRT des Knochenmarks zum Monitoring des Multiplen Myeloms unter Thalidomid-Monotherapie oder Kombination mit CED-Chemotherapie. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 176(9). 1285–1295. 12 indexed citations
12.
Hensel, M., Gerlinde Egerer, Andreas Schneeweiß, H. Goldschmidt, & Anthony D. Ho. (2002). Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Annals of Oncology. 13(2). 209–217. 70 indexed citations
13.
Hegenbart, Ute, et al.. (2001). Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone. Supportive Care in Cancer. 9(5). 380–385. 5 indexed citations
14.
Witzens‐Harig, Mathias, et al.. (2001). Successful Treatment of Bronchiolitis obliterans Organizing Pneumonia with Low-Dose Methotrexate in a Patient with Hodgkin’s Disease. Oncology. 61(1). 23–27. 9 indexed citations
15.
Waldmann, V., H. Goldschmidt, Andreas Jäckel, et al.. (2000). Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation. British Journal of Dermatology. 143(4). 837–839. 13 indexed citations
16.
Goldschmidt, H. & R Arnold. (1999). Session VII: Hematopoietic stem cell transplantation in autoimmune diseases (and further topics). Bone Marrow Transplantation. 23(S3). S14–S14. 1 indexed citations
17.
18.
Möhle, Robert, S. Frühauf, H. Goldschmidt, et al.. (1994). Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 83(12). 3787–3794. 10 indexed citations
19.
Mihatsch, M. J., et al.. (1974). Bladder Necrosis Caused By Use Of Tham In A Newborn Infant. The Journal of Urology. 111(6). 835–837. 9 indexed citations
20.
Goldschmidt, H., et al.. (1972). [Familial occurrence of anorectal abnormalities associated with vertebral abnormalities].. PubMed. 27(4). 361–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Carobolante Breakdown of academic impact, for papers by Christine M. Segeren Breakdown of academic impact, for papers by MR Litzow Breakdown of academic impact, for papers by M Gaspard Breakdown of academic impact, for papers by Laura Cannella Breakdown of academic impact, for papers by Diane Weber Breakdown of academic impact, for papers by Clifton C. Mo Breakdown of academic impact, for papers by Natalie Pui Ha Chan Breakdown of academic impact, for papers by Anna Pawłowska Breakdown of academic impact, for papers by Samer Al Hadidi
Rankless by CCL
2026